Docoh
Loading...

ABIO ARCA biopharma

Employees

Data from SEC filings
Employee count

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM


On July 8, 2021, the Company held the 2021 Annual Meeting at which the Company’s stockholders voted upon (i) the election of Company nominees, Dr. Raymond Woosley and Mr. Dan Mitchell, to the Board for a three-year term ending at the 2024 Annual Meeting of Stockholders, (ii) the ratification of the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 and (iii) the approval of, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement.

The stockholders elected the director nominees, ratified the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021, and approved the resolution concerning the advisory vote on the compensation of the Company’s named executive officers. The tabulation of votes cast with respect to each matter voted upon, as applicable, was as follows:

1. Election of Directors:

NomineeForWithheldBroker Non-Votes
Dr. Raymond Woosley1,555,220 698,9114,064,222
Mr. Dan Mitchell1,562,242 691,8894,064,222


2. Ratification of the selection of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021:

ForAgainstAbstentionsBroker Non-Votes
6,010,419252,97354,961


3. Executive Compensation:

ForAgainstAbstentionsBroker Non-Votes
1,395,198750,488108,4454,064,222